Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

NCT06468644 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: chemoradiotherapy （CRT）+sintilimab 1
DRUG: CRT+sintilimab 2

Sponsor

Fujian Cancer Hospital